权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Identification and Analysis of Flavivirus Protease and RNA Helicase Inhibitors

黄病毒蛋白酶和 RNA 解旋酶抑制剂的鉴定和分析

基本信息

批准号：
7909725
负责人：
Radhakrishnan Padmanabhan
金额：
$ 9.88万
依托单位：
GEORGETOWN UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-09-01 至 2011-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7909725
关键词：
3&apos Untranslated Regions Active Sites Affinity Amino Acids Antiviral Agents Binding Biochemical Biological Biological Assay Bovine Viral Diarrhea Viruses Cells Collaborations Complex Computer Assisted Crystallization Culicidae Dengue Development Disease Docking Electrophoretic Mobility Shift Assay Encephalitis Enzymes Escherichia coli Event Exhibits Flavivirus Fluorescence Resonance Energy Transfer Genome Goals Hand Hepatitis Hepatitis C virus Human Hydrolysis Immunoprecipitation In Vitro Individual Kinetics Laboratories Lead Length Letters Libraries Life Cycle Stages Light Measurement Measures Methods Methyltransferase Molecular Morbidity - disease rate N-terminal National Institute of Allergy and Infectious Disease Nature Nonstructural Protein Open Reading Frames Outcome Study Pathogenesis Pathway interactions Peptide Hydrolases Peptides Polyproteins Process Property Protease Domain Proteins RNA RNA Helicase RNA replication RNA triphosphatase RNA-Directed RNA Polymerase Replicon Reporter Reporting Research Research Personnel Role Screening procedure Serine Protease Serotyping Spectrum Analysis Structure Surface Plasmon Resonance Symptoms Testing Therapeutic Translating Translations Viral Viral Hemorrhagic Fevers Viral Nonstructural Proteins Virus West Nile virus Yellow fever virus base cofactor cytotoxicity enzyme activity flu guanylyltransferase helicase high throughput screening in vitro Assay inhibitor/antagonist inorganic phosphate insight molybdenum blue mortality novel nucleoside triphosphatase pathogen programs small molecule tool viral RNA virus host interaction

项目摘要

DESCRIPTION (provided by applicant): The mosquito-borne flaviviruses include the NIAID list of Class A, B, or C emerging human pathogens such as Yellow fever virus (YFV), West Nile virus (WNV) and Dengue (DEN1-4) viruses that cause serious illnesses with considerable morbidity and mortality. These viruses, in addition to flu-like symptoms, can cause hemorrhagic fevers (YFV and DEN) or encephalitis and/or meningo-encephalitis in susceptible humans. One of the long term goals of this laboratory has been to develop antiviral therapeutics through understanding of key pathways in the viral life cycle using in vitro enzymatic assays that mimic those utilized by these viruses in their natural hosts. Two of the nonstructural proteins, NS3 and NS5, have multiple enzyme activities that are required for the virus life cycle. NS3, in association with NS2B, is a serine protease that is required for polyprotein processing, a key early event in the virus life cycle. Moreover, NS3 exhibits an RNA-stimulated NTPase, RNA helicase and the 5'-RNA triphosphatase (5'-RTPase) activities. The NTPase and 5'-RTPase activities are stimulated by interaction with NS5, the viral 5'-RNA methyltransferase and the RNA dependent RNA polymerase (RdRP). These enzyme activities are excellent targets for development of antiviral therapeutics. In Specific Aim 1, we propose test the hypothesis that small molecule compounds could potentially inhibit the interaction between the NS2B cofactor and the NS3 protease (NS3-pro) domain or by mimicking the substrate-protease interactions or both. To this hypothesis, we will screen approximately 175,000 compounds in the National Screening Laboratory using the in vitro protease assay. By using chemoinformatics and computer-assisted docking studies and the crystal structure of the DEN protease domain, we will select about 100 compounds with greater than or equal to 50% inhibition of (i) interaction between the NS2B cofactor-NS3-pro domain and (ii) interaction between the substrate-protease active site interaction by measuring the Kcat and Km values in the presence and absence of inhibitors. Further testing of selected compounds will be performed using cytotoxicity, viral infectivity and replicon-based assays. In Specific Aim 2, the hypothesis that small molecule compounds that could potentially inhibit NS3/NS5 interaction and block their individual functions will be tested. We will identify approximately 200 compounds using a similar strategy as in Aim 1 but by using the in vitro assay based on measurement of the Pi released from the hydrolysis of either NTP or the 5'-triphosphorylated RNA and the recently reported crystal structures of YFV and DEN2 RNA helicases and those of hepatitis C virus and bovine viral diarrhea virus (BVDV) RdRP for docking studies. Inhibitors of interaction between NS3-RNA, NS3-NTP, NS3-NS5 will be analyzed by immunoprecipitation, surface plasmon resonance and gel shift assays. Further testing of selected compounds will be performed using cytotoxicity, viral infectivity and replicon-based reporter assays. This proposed research is likely lead to identification of novel inhibitors that will be useful for co-crystallization and structure-function studies that could provide valuable insight into the nature of molecular interactions among flavivirus nonstructural proteins in the flavivirus life cycle.

描述（由申请方提供）：蚊媒黄病毒包括NIAID列表中的A类、B类或C类新兴人类病原体，如黄热病病毒（YFV）、西尼罗河病毒（WNV）和登革热（DEN 1 -4）病毒，这些病毒可引起严重疾病，具有相当高的发病率和死亡率。除了流感样症状外，这些病毒还可在易感人群中引起出血热（YFV和DEN）或脑炎和/或脑膜脑炎。该实验室的长期目标之一是通过了解病毒生命周期中的关键途径来开发抗病毒治疗方法，该方法使用体外酶测定法模拟这些病毒在其天然宿主中所利用的酶测定法。其中两种非结构蛋白NS 3和NS 5具有病毒生命周期所需的多种酶活性。与NS 2B相关的NS 3是多蛋白加工所需的丝氨酸蛋白酶，多蛋白加工是病毒生命周期中的关键早期事件。此外，NS 3表现出RNA刺激的NTR酶、RNA解旋酶和5 '-RNA三磷酸酶（5'-RTR酶）活性。通过与NS 5、病毒5 '-RNA甲基转移酶和RNA依赖性RNA聚合酶（RdRP）的相互作用刺激NTR和5'-RTR活性。这些酶活性是开发抗病毒治疗剂的极好靶点。在具体目标1中，我们提出测试以下假设：小分子化合物可以潜在地抑制NS 2B辅因子和NS 3蛋白酶（NS 3-pro）结构域之间的相互作用或通过模拟底物-蛋白酶相互作用或两者。根据这一假设，我们将在国家筛选实验室使用体外蛋白酶测定法筛选约175，000种化合物。通过使用化学信息学和计算机辅助对接研究以及DEN蛋白酶结构域的晶体结构，我们将选择约100种化合物，其通过测量存在和不存在抑制剂的情况下的Kcat和Km值，对（i）NS 2B辅因子-NS 3-pro结构域之间的相互作用和（ii）底物-蛋白酶活性位点之间的相互作用具有大于或等于50%的抑制。将使用细胞毒性、病毒感染性和基于复制子的试验对选定化合物进行进一步检测。在特定目标2中，将检验可能抑制NS 3/NS 5相互作用并阻断其个体功能的小分子化合物的假设。我们将使用与目标1相似的策略鉴别约200种化合物，但使用基于NTP或5 '-三磷酸化RNA水解释放的Pi测量值的体外试验以及最近报道的YFV和DEN 2 RNA解旋酶晶体结构以及丙型肝炎病毒和牛病毒性腹泻病毒（BVDV）RdRP的晶体结构进行对接研究。NS 3-RNA、NS 3-NTP、NS 3-NS 5之间相互作用的抑制剂将通过免疫沉淀、表面等离子体共振和凝胶位移测定进行分析。将使用细胞毒性、病毒感染性和基于复制子的报告基因试验对选定化合物进行进一步检测。这项拟议的研究可能会导致识别新的抑制剂，这将是有用的共结晶和结构-功能研究，可以提供有价值的洞察黄病毒生命周期中的黄病毒非结构蛋白之间的分子相互作用的性质。